Found "Vaccines": 76 results
HPV vaccine found safe in large study
(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.“This analysis was v
HITAP joined the stakeholders meeting on Economic Evaluation of Human Papillomavirus Vaccine (HPV) and Pneumococcal Conjugate Vaccine (PCV) in Philippines
This is the third visit of the HITAP team to the Philippines and last activity of the two vaccine evaluations project collaboration between NCPAM and HITAP with the support of Rockefeller Foundation through NICE International. The project started in March 2013 and ended in March 2014. With extensive
PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)
PMAC 2016 Side Event (SE 012): Health Intervention and Technology Assessment (HITA): A Path to Universal Health Coverage (UHC)Given the global push to implement UHC, the importance of using evidence, namely health intervention and technology assessments (HITA), in governments’ decision making proces
India to establish Medical Technology Assessment Board
Rhythma Kaul / Hindustand TimesNew Delhi: India announced the setting up of a Medical Technology Assessment Board (MTAB) that will be one-stop shop to review standards for medicines, vaccines, devices and insurance.The Board’s recommendations will be the last word for health policies and healthcare
Bhutan’s oldest newspaper shows appreciation on iDSI’s support to evaluate new vaccines in Bhutan
Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp
Join us in the Vaccinology Workshop on November 18-21 in India!
The Health Intervention and Technology Assessment Program (HITAP) would like to invite you to join and learn more about vaccines in a Policy Symposium and Workshop on Vaccinology for Clinical and Public Health Practice in Faridabad (near Delhi), India, on 18-21 November 2019.
Join this event to
HITAP emphasises Thailand’s leadership in health system as the host of the Health Technology Assessment (HTA) conference at the regional level gathering around 300 academics from 20 countries
HITAP emphasise the lead role of Thailand in public health system as the host of the Health Technology Assessment (HTA) conference at the regional level gathering around 300 academics from 20 countries to present their research work, build a network for health policy recommendations development, and
[Press Release] 5 Leading Agencies Join Forces to Promote Early Health Technology Assessment for Development of Medical and Healthcare Innovations in Thailand
On June 19, 2023, the Health Intervention and Technology Assessment Program Foundation (HITAP Foundation), in collaboration with the Saw Swee Hock School of Public Health of the National University of Singapore (NUS), organized a workshop on “Fruitful Research: How to Make Health Innovation Worthwhi
IDSI Philippines
This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker
Maternal Child and Health Voucher Scheme (MCHVS)
In 2008, Myanmar proposed the development of a Health System Strengthening (HSS) programme to the Global Alliance for Vaccines and Immunization (GAVI) and thus received funding and support for its initiative. The HSS framework aimed to shore up three main gaps which were identified: service delivery, programme coordination, and human resources. Ser
10 / Page